Palette Life Sciences
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Palette Life Sciences, founded in 2018 with headquarters in Santa Barbara, California and Stockholm, Sweden, was a medical device company developing and commercializing injectable gels. Its portfolio included Barrigel for rectal wall protection during prostate radiotherapy, Deflux for vesicoureteral reflux, Solesta for fecal incontinence and Lidbree, serving urology, urogynecology, colorectal and interventional oncology applications. In October 2023 it was acquired by Teleflex for an upfront cash payment of $600 million plus up to $50 million in commercial-milestone consideration.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Palette Life Sciences is founded with bases in Santa Barbara, California and Stockholm, Sweden, to develop injectable medical gels.
- Acquisition
Teleflex announces the definitive agreement on July 26, 2023 and completes the acquisition on October 10, 2023 for $600 million upfront plus up to $50 million in milestones.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.